| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $860.2M | -2.9% | +26.1% |
| Cost of Revenue | $662.8M | — | +28.2% |
| R&D Expense | $4.1M | — | +103.7% |
| SG&A Expense | $108.0M | — | +23.4% |
| Operating Income | $106.7M | +15.9% | +10.4% |
| Pre-tax Income | $107.3M | — | +16.9% |
| Income Tax | $16.1M | — | -1.0% |
| Net Income | $91.1M | -2.1% | +20.7% |
| EPS (Basic) | $0.99 | -2.9% | +20.7% |
| EPS (Diluted) | $0.99 | -2.0% | +20.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $512.4M | +2.5% | +824.2% |
| Accounts Receivable | $185.2M | -16.0% | +107.8% |
| Inventory | $45.6M | -2.0% | -8.2% |
| Current Assets | $1.62B | +3.6% | +65.6% |
| Total Assets | $4.32B | +1.3% | +41.6% |
| Current Liabilities | $674.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $92.6M | — | +82.8% |
| Capital Expenditures | $42.5M | — | +27.4% |
| Investing Cash Flow | -$46.9M | — | +70.0% |
| Financing Cash Flow | -$34.2M | — | -140.3% |
| Free Cash Flow | $50.1M | — | +189.9% |
| +39.3% |
| Long-term Debt | $2.02B | +0.1% | +70.2% |
| Total Liabilities | $3.04B | +0.2% | — |
| Stockholders' Equity | $1.28B | +3.9% | +16.4% |